Eculizumab Therapy for Chronic Antibody-Mediated Injury in Kidney Transplantation: An Interim Assessment.

被引：0
|
作者：
Kulkarni, S. [1 ]
Kirkles-Smith, N. [1 ]
Tomlin, R. [1 ]
Formica, R. [1 ]
Moeckel, G. [1 ]
Pober, J. [1 ]
机构：
[1] Yale Univ, Sch Med, New Haven, CT USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2013年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：86 / 86
页数：1
相关论文
共 50 条
  • [1] Eculizumab Therapy for Chronic Antibody-Mediated Injury in Kidney Transplantation: An Interim Assessment
    Kulkarni, S.
    Nancy, K.
    Formica, R.
    Moeckel, G.
    Pober, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 79 - 79
  • [2] Eculizumab Therapy for Chronic Antibody-Mediated Injury in Kidney Transplantation: An Interim Assessment
    Kulkarni, S.
    Nancy, K.
    Formica, R.
    Moeckel, G.
    Pober, J.
    TRANSPLANTATION, 2014, 98 : 79 - 79
  • [3] Eculizumab Therapy for Chronic Antibody-Mediated Injury in Kidney Transplant Recipients: A Pilot Randomized Controlled Trial
    Kulkarni, S.
    Kirkiles-Smith, N. C.
    Deng, Y. H.
    Formica, R. N.
    Moeckel, G.
    Broecker, V.
    Bow, L.
    Tomlin, R.
    Pober, J. S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 (03) : 682 - 691
  • [4] Dosing Eculizumab for Antibody-Mediated Rejection in Kidney Transplantation: A Case Report
    Smith, B.
    Kumar, V.
    Mompoint-Williams, D.
    Reed, R. D.
    MacLennan, P. A.
    Stegner, K.
    Locke, J. E.
    TRANSPLANTATION PROCEEDINGS, 2016, 48 (09) : 3099 - 3105
  • [5] Eculizumab for Chronic Antibody-Mediated Injury in Kidney Transplant Recipients: A Randomized-Controlled Trial.
    Kulkarni, S.
    Kirkiles-Smith, N.
    Deng, Y.
    Formica, R.
    Gilbert, M.
    Broeckner, V.
    Bow, L.
    Pober, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 : 475 - 476
  • [6] Belatacept for Chronic Antibody-Mediated Rejection in Kidney Transplantation
    Kumar, D.
    Gupta, G.
    Reeve, J.
    Sanghi, P.
    Bobba, S.
    Levy, M.
    Bhati, C.
    Kimball, P.
    Fattah, H.
    King, A.
    Massey, H.
    Halloran, P.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 310 - 310
  • [7] Eculizumab Therapy for Late Antibody-Mediated Rejection in Pediatric Kidney Transplant Patients
    Siddiqui, Meraj Alam
    Baskin, Esra
    Karakayali, Feza Yarbug
    Gemici, Atilla
    Gulleroglu, Kaan
    Yilmaz, Aysun Caltik
    Moray, Gokhan
    Haberal, Mehmet
    TRANSPLANTATION, 2022, 106 (09) : S445 - S445
  • [8] ECULIZUMAB IN ANTIBODY-MEDIATED REJECTION OF PAEDIATRIC RENAL TRANSPLANTATION
    Roman-Ortiz, Elena
    Mendizabal, Santiago
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [9] Eculizumab and Splenectomy as Salvage Therapy for Severe Antibody-Mediated Rejection After HLA-Incompatible Kidney Transplantation
    Orandi, Babak J.
    Zachary, Andrea A.
    Dagher, Nabil N.
    Bagnasco, Serena M.
    Garonzik-Wang, Jacqueline M.
    Van Arendonk, Kyle J.
    Gupta, Natasha
    Lonze, Bonnie E.
    Alachkar, Nada
    Kraus, Edward S.
    Desai, Niraj M.
    Locke, Jayme E.
    Racusen, Lorraine C.
    Segev, Dorry L.
    Montgomery, Robert A.
    TRANSPLANTATION, 2014, 98 (08) : 857 - 863
  • [10] Reversal of refractory antibody-mediated rejection in blood group incompatible kidney transplantation by Eculizumab
    Morath, C.
    Kihm, L. P.
    Zeier, M.
    Waldher, R.
    Schmidt, J.
    Leo, A.
    Suesal, C.
    Kirschfink, M.
    MOLECULAR IMMUNOLOGY, 2011, 48 (14) : 1677 - 1677
12345